PTCT

#2358
PTC Therapeutics, Inc. - Common Stock
73.8 5 USD
+3.94%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
73.85
73.85
Faixa anual
44.17
87.50
Mudança diária
+3.94%
Mudança mensal
+13.98%
Mudança em 6 meses
-11.23%
Mudança anual
+50.99%
Fechamento anterior
71.0 5
Open
73.8 5
Mínimo
73.8 5
High
73.8 5
Volume
158
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
Demonstração de resultados Balanço patrimonial Fluxo de caixa
Valor Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM

PTC Therapeutics, Inc. - Common Stock

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control mechanisms in orphan diseases. In September 2009, PTC entered into an agreement with Roche for the development of orally bioavailable small molecules for central nervous system diseases. PTC acquired the Bio-e platform in 2019.

Notícias